Bonraybio Co., Ltd. (TPE:6955)
Taiwan · Delayed Price · Currency is TWD 93.00
0.00 (0.00%)
Oct 8, 2026, 12:05 PM CST
Bonraybio Market Cap
Bonraybio has a market cap or net worth of 2.83 billion as of October 8, 2026. It is the 26,299th most valuable company in the world and the 1,450th biggest in Taiwan. Its market cap has decreased by 32.19% in one year.
Market Cap
2.83B
Enterprise Value
2.30B
Revenue
332.21M
Global Rank
Country Rank
#1,450 Taiwan
PE Ratio
26.25
ChartMarket Cap Chart
Since July 25, 2023, Bonraybio's market cap has increased from 1.48B to 2.83B, an increase of 91.40%. That is a compound annual growth rate of 22.43%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2026 | 2.83B | -23.02% |
| Dec 31, 2025 | 3.67B | 24.12% |
| Dec 31, 2024 | 2.96B | 101.25% |
| Dec 29, 2023 | 1.47B | -0.46% |
| Jul 25, 2023 | 1.48B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| WeLeader Biomedical | 3.34B |
| Apex Biotechnology | 2.98B |
| Applied BioCode | 2.73B |
| A Plus Biotechnology | 2.52B |
| Wellell | 2.44B |
| Medimaging Integrated Solution | 2.25B |
| Dynamic Medical Technologies | 2.14B |
| OK Biotech | 1.95B |